{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:37:25Z","timestamp":1782740245271,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent headache is a frequent symptom after coronavirus disease 2019 (COVID-19) and there is currently limited knowledge about its clinical spectrum and predisposing factors. A subset of patients may be experiencing new daily persistent headache (NDPH) after COVID-19, which is among the most treatment-refractory primary headache syndromes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study in Latin America to characterize individuals with persistent headache after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to identify factors associated with NDPH. Participants over 18 years old who tested positive for SARS-CoV-2 infection and reported persistent headache among their symptoms completed an online survey that included demographics, past medical history, persistent headache clinical characteristics, and COVID-19 vaccination status. Based on participants\u2019 responses, NDPH diagnostic criteria were used to group participants into NDPH and non-NDPH groups. Participant data was summarized by descriptive statistics. Student\u2019s t and Mann\u2013Whitney U tests were used according to the distribution of quantitative variables. For categorical variables, Pearson\u2019s chi-square and Fisher\u2019s exact tests were used according to the size of expected frequencies. Binomial logistic regression using the backward stepwise selection method was performed to identify factors associated with NDPH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four hundred and twenty-one participants from 11 Latin American countries met the inclusion criteria. One in four participants met the NDPH diagnostic criteria. The mean age was 40 years, with most participants being female (82%). Over 90% of the participants reported having had mild\/moderate COVID-19. Most participants had a history of headache before developing COVID-19 (58%), mainly migraine type (32%). The most predominant clinical characteristics in the NDPH group were occipital location, severe\/unbearable intensity, burning character, and radiating pain (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). A higher proportion of anxiety symptoms, sleep problems, myalgia, mental fog, paresthesia, nausea, sweating of the face or forehead, and ageusia or hypogeusia as concomitant symptoms were reported in participants with NDPH (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Palpebral edema as a concomitant symptom during the acute phase of COVID-19, occipital location, and burning character of the headache were risk factors associated with NDPH.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first study in Latin America that explored the clinical spectrum of NDPH after SARS-CoV-2 infection and its associated factors. Clinical evaluation of COVID-19 patients presenting with persistent headache should take into consideration NDPH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08898-2","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T14:03:10Z","timestamp":1702562590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Fhabi\u00e1n S.","family":"Carri\u00f3n-Nessi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis C.","family":"Ascanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre\u00edna G.","family":"Pineda-Arap\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar D.","family":"Oma\u00f1a-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela L.","family":"Mendoza-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinibaldo R.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abranny B.","family":"Almao-Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"Camejo-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim J.","family":"Gebran-Chedid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlis M.","family":"Rodriguez-Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Freitas-De Nobrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Forero-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes A.","family":"Delgado-Noguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucianny K.","family":"Meneses-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Cotu\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso J.","family":"Rodriguez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Forero-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto E.","family":"Paniz-Mondolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"8898_CR1","unstructured":"WHO Coronavirus (COVID-19.) Dashboard [https:\/\/covid19.who.int\/]."},{"key":"8898_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2020.05.037","volume":"88","author":"C Liguori","year":"2020","unstructured":"Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 Infection. Brain Behav Immun. 2020;88:11\u20136.","journal-title":"Brain Behav Immun"},{"issue":"10223","key":"8898_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus Pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"6","key":"8898_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683\u201390.","journal-title":"JAMA Neurol"},{"issue":"8","key":"8898_CR5","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","volume":"95","author":"CM Romero-S\u00e1nchez","year":"2020","unstructured":"Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Fern\u00e1ndez-D\u00edaz E, S\u00e1nchez-Larsen \u00c1, Layos-Romero A, Garc\u00eda-Garc\u00eda J, Gonz\u00e1lez E, Redondo-Pe\u00f1as I, Perona-Moratalla AB, Del Valle-P\u00e9rez JA, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060\u201370.","journal-title":"Neurology"},{"issue":"8","key":"8898_CR6","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00415-020-10285-9","volume":"268","author":"F Cagnazzo","year":"2021","unstructured":"Cagnazzo F, Arquizan C, Derraz I, Dargazanli C, Lefevre PH, Riquelme C, Gaillard N, Mourand I, Gascou G, Bonafe A, et al. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol. 2021;268(8):2656\u201365.","journal-title":"J Neurol"},{"issue":"2","key":"8898_CR7","doi-asserted-by":"publisher","first-page":"104090","DOI":"10.1016\/j.lpm.2021.104090","volume":"51","author":"J Hugon","year":"2022","unstructured":"Hugon J. Long-COVID: cognitive deficits (brain fog) and brain lesions in non-hospitalized patients. Presse Med. 2022;51(2):104090.","journal-title":"Presse Med"},{"issue":"1","key":"8898_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-022-01450-8","volume":"23","author":"C Tana","year":"2022","unstructured":"Tana C, Bentivegna E, Cho SJ, Harriott AM, Garc\u00eda-Azor\u00edn D, Labastida-Ramirez A, Ornello R, Raffaelli B, Beltr\u00e1n ER, Ruscheweyh R, et al. Long COVID headache. J Headache Pain. 2022;23(1):93.","journal-title":"J Headache Pain"},{"issue":"11","key":"8898_CR9","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1111\/ene.15040","volume":"28","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Navarro-Santana M, G\u00f3mez-Mayordomo V, Cuadrado ML, Garc\u00eda-Azor\u00edn D, Arendt-Nielsen L, Plaza-Manzano G. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820\u20135.","journal-title":"Eur J Neurol"},{"issue":"13","key":"8898_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1177\/03331024211020404","volume":"41","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, G\u00f3mez-Mayordomo V, Cuadrado ML, Palacios-Ce\u00f1a D, Florencio LL, Guerrero AL, Garc\u00eda-Azor\u00edn D, Hern\u00e1ndez-Barrera V, Arendt-Nielsen L. The presence of headache at onset in SARS-CoV-2 Infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021;41(13):1332\u201341.","journal-title":"Cephalalgia"},{"issue":"13","key":"8898_CR11","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1177\/0333102420965157","volume":"40","author":"E Caronna","year":"2020","unstructured":"Caronna E, Ballv\u00e9 A, Llaurad\u00f3 A, Gallardo VJ, Ariton DM, Lallana S, L\u00f3pez Maza S, Oliv\u00e9 Gadea M, Quibus L, Restrepo JL, et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40(13):1410\u201321.","journal-title":"Cephalalgia"},{"issue":"8","key":"8898_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/head.13941","volume":"60","author":"PA Sampaio Rocha-Filho","year":"2020","unstructured":"Sampaio Rocha-Filho PA, Voss L. Persistent headache and persistent Anosmia Associated with COVID-19. Headache. 2020;60(8):1797\u20139.","journal-title":"Headache"},{"issue":"11","key":"8898_CR13","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1111\/ene.15084","volume":"28","author":"L Dearing","year":"2021","unstructured":"Dearing L, M\u00fcller F, Sellner J. Headache with SARS-CoV-2 Infection: A matter of concern. Eur J Neurol. 2021;28(11):3554\u20135.","journal-title":"Eur J Neurol"},{"issue":"8","key":"8898_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/head.14197","volume":"61","author":"E Caronna","year":"2021","unstructured":"Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: three migraine-like yet distinct scenarios. Headache. 2021;61(8):1277\u201380.","journal-title":"Headache"},{"issue":"10","key":"8898_CR15","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1007\/s10072-021-05444-3","volume":"42","author":"F Dono","year":"2021","unstructured":"Dono F, Consoli S, Evangelista G, D\u2019Apolito M, Russo M, Carrarini C, Calisi D, De Rosa M, Di Pietro M, De Angelis MV, et al. New daily persistent headache after SARS-CoV-2 Infection: a report of two cases. Neurol Sci. 2021;42(10):3965\u20138.","journal-title":"Neurol Sci"},{"issue":"1","key":"8898_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee o","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International classification of Headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"13","key":"8898_CR17","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1177\/0333102420965132","volume":"40","author":"TD Rozen","year":"2020","unstructured":"Rozen TD. Daily persistent headache after a viral Illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian\/Asiatic Flu. Cephalalgia. 2020;40(13):1406\u20139.","journal-title":"Cephalalgia"},{"key":"8898_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2022.04.009","volume":"132","author":"AC Simmons","year":"2022","unstructured":"Simmons AC, Bonner A, Giel A, Pezzano A, Rothner AD. Probable New Daily Persistent Headache after COVID-19 in children and adolescents. Pediatr Neurol. 2022;132:1\u20133.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"8898_CR19","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejp.1755","volume":"25","author":"FHC Soares","year":"2021","unstructured":"Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, Lapa J, Braga LM, Almeida MM, Cunha P, et al. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur J Pain. 2021;25(6):1342\u201354.","journal-title":"Eur J Pain"},{"key":"8898_CR20","unstructured":". In: Coronavirus Disease 2019 (COVID-19) treatment guidelines. edn. Bethesda (MD): National Institutes of Health (US); 2021."},{"key":"8898_CR21","unstructured":"Long COVID. [https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html#:~:text=Some%20people%2C%20especially%20those%20who,kidney%2C%20skin%2C%20and%20brain]."},{"key":"8898_CR22","unstructured":"PAHO\/WHO: PAHO Weekly COVID-19 Epidemiological Update \u2013\u200912 April 2022. In., vol. 2022. Washington, D.C.: Pan American Health Organization\/World Health Organization; 2022."},{"key":"8898_CR23","first-page":"317","volume":"26","author":"W Vanast","year":"1986","unstructured":"Vanast W. New daily persistent headache: definition of a benign syndrome. Headache. 1986;26:317.","journal-title":"Headache"},{"issue":"10","key":"8898_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/head.14207","volume":"61","author":"RW Evans","year":"2021","unstructured":"Evans RW, Turner DP. Clinical features of new daily persistent headache: a retrospective chart review of 328 cases. Headache. 2021;61(10):1529\u201338.","journal-title":"Headache"},{"issue":"1","key":"8898_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/head.12707","volume":"56","author":"TD Rozen","year":"2016","unstructured":"Rozen TD. Triggering events and New Daily Persistent Headache: age and gender differences and insights on Pathogenesis-A clinic-based study. Headache. 2016;56(1):164\u201373.","journal-title":"Headache"},{"issue":"17","key":"8898_CR26","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1212\/WNL.0b013e3181dad5de","volume":"74","author":"MS Robbins","year":"2010","unstructured":"Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010;74(17):1358\u201364.","journal-title":"Neurology"},{"issue":"3","key":"8898_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1046\/j.1526-4610.1999.3903190.x","volume":"39","author":"J Castillo","year":"1999","unstructured":"Castillo J, Mu\u00f1oz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999;39(3):190\u20136.","journal-title":"Headache"},{"issue":"11","key":"8898_CR28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1468-2982.2009.01842.x","volume":"29","author":"RB Grande","year":"2009","unstructured":"Grande RB, Aaseth K, Lundqvist C, Russell MB. Prevalence of new daily persistent headache in the general population. The Akershus Study of Chronic Headache Cephalalgia. 2009;29(11):1149\u201355.","journal-title":"The Akershus Study of Chronic Headache Cephalalgia"},{"issue":"5","key":"8898_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1212\/01.WNL.0000137039.08724.18","volume":"63","author":"ME Bigal","year":"2004","unstructured":"Bigal ME, Lipton RB, Tepper SJ, Rapoport AM, Sheftell FD. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology. 2004;63(5):843\u20137.","journal-title":"Neurology"},{"issue":"11","key":"8898_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1468-2982.2004.00771.x","volume":"24","author":"Y Takase","year":"2004","unstructured":"Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug-based treatment, and prognosis of new daily persistent headache (NDPH): 30 cases in Japan. Cephalalgia. 2004;24(11):955\u20139.","journal-title":"Cephalalgia"},{"issue":"1","key":"8898_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1468-2982.2008.01647.x","volume":"29","author":"E Kung","year":"2009","unstructured":"Kung E, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. New daily persistent headache in the paediatric population. Cephalalgia. 2009;29(1):17\u201322.","journal-title":"Cephalalgia"},{"issue":"1","key":"8898_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s10194-019-1022-z","volume":"20","author":"N Yamani","year":"2019","unstructured":"Yamani N, Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. J Headache Pain. 2019;20(1):80.","journal-title":"J Headache Pain"},{"issue":"15","key":"8898_CR33","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1177\/0333102411424620","volume":"31","author":"KP Peng","year":"2011","unstructured":"Peng KP, Fuh JL, Yuan HK, Shia BC, Wang SJ. New daily persistent headache: should migrainous features be incorporated? Cephalalgia. 2011;31(15):1561\u20139.","journal-title":"Cephalalgia"},{"issue":"8530","key":"8898_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0140-6736(87)90119-X","volume":"1","author":"F Diaz-Mitoma","year":"1987","unstructured":"Diaz-Mitoma F, Vanast WJ, Tyrrell DL. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet. 1987;1(8530):411\u20135.","journal-title":"Lancet"},{"issue":"13","key":"8898_CR35","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1177\/0333102420965146","volume":"40","author":"JT L\u00f3pez","year":"2020","unstructured":"L\u00f3pez JT, Garc\u00eda-Azor\u00edn D, Planchuelo-G\u00f3mez \u00c1, Garc\u00eda-Iglesias C, Due\u00f1as-Guti\u00e9rrez C, Guerrero \u00c1L. Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020;40(13):1432\u201342.","journal-title":"Cephalalgia"},{"key":"8898_CR36","doi-asserted-by":"publisher","first-page":"120591","DOI":"10.1016\/j.jns.2023.120591","volume":"446","author":"A Torrente","year":"2023","unstructured":"Torrente A, Alonge P, Di Stefano V, Baschi R, Ornello R, Correnti E, Lupica A, Camarda C, Farinella G, Raieli V, et al. New-onset headache following COVID-19: an Italian multicentre case series. J Neurol Sci. 2023;446:120591.","journal-title":"J Neurol Sci"},{"issue":"6","key":"8898_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10194-012-0461-6","volume":"13","author":"S Prakash","year":"2012","unstructured":"Prakash S, Saini S, Rana KR, Mahato P. Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India. J Headache Pain. 2012;13(6):477\u201385.","journal-title":"J Headache Pain"},{"issue":"Suppl 3","key":"8898_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10072-004-0310-8","volume":"25","author":"P Meineri","year":"2004","unstructured":"Meineri P, Torre E, Rota E, Grasso E. New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci. 2004;25(Suppl 3):281\u20132.","journal-title":"Neurol Sci"},{"issue":"1","key":"8898_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1046\/j.1468-2982.2002.00326.x","volume":"22","author":"D Li","year":"2002","unstructured":"Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22(1):66\u20139.","journal-title":"Cephalalgia"},{"key":"8898_CR40","doi-asserted-by":"crossref","unstructured":"Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho SM. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 2023, 12(5).","DOI":"10.3390\/cells12050816"},{"key":"8898_CR41","doi-asserted-by":"crossref","unstructured":"Foo S-S, Chen W, Jung KL, Azamor T, Choi UY, Zhang P, Comhair SA, Erzurum SC, Jehi L, Jung JU. Immunometabolic rewiring in long COVID patients with chronic headache. 2023:2023.2003.2006.531302.","DOI":"10.1101\/2023.03.06.531302"},{"key":"8898_CR42","volume-title":"A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021","author":"O World Health","year":"2021","unstructured":"World Health O. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. In. Geneva: World Health Organization; 2021."},{"issue":"10","key":"8898_CR43","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1177\/08830738211004514","volume":"36","author":"E Strong","year":"2021","unstructured":"Strong E, Pierce EL, Langdon R, Strelzik J, McClintock W, Cameron M, Furda M, DiSabella M. New Daily Persistent Headache in a Pediatric Population. J Child Neurol. 2021;36(10):888\u201393.","journal-title":"J Child Neurol"},{"issue":"2","key":"8898_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/14737175.2023.2185138","volume":"23","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2023","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Cuadrado ML, G\u00f3mez-Mayordomo V, Garc\u00eda-Azor\u00edn D, Arendt-Nielsen L. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 variant. Expert Rev Neurother. 2023;23(2):179\u201386.","journal-title":"Expert Rev Neurother"},{"issue":"Supplement","key":"8898_CR45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0028-3886.315983","volume":"69","author":"S Cheema","year":"2021","unstructured":"Cheema S, Matharu M. Cluster headache: what\u2019s New? Neurol India. 2021;69(Supplement):124\u2013s134.","journal-title":"Neurol India"},{"issue":"4","key":"8898_CR46","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1212\/WNL.0000000000010979","volume":"96","author":"JA Frontera","year":"2021","unstructured":"Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City. Neurology. 2021;96(4):e575\u201386.","journal-title":"Neurology"},{"issue":"3","key":"8898_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3988\/jcn.2021.17.3.435","volume":"17","author":"HK Kim","year":"2021","unstructured":"Kim HK, Cho YJ, Lee SY. Neurological manifestations in patients with COVID-19: experiences from the Central Infectious Diseases Hospital in South Korea. J Clin Neurol (Seoul Korea). 2021;17(3):435\u201342.","journal-title":"J Clin Neurol (Seoul Korea)"},{"issue":"10","key":"8898_CR48","first-page":"737","volume":"53","author":"SJ Yong","year":"2021","unstructured":"Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases. (London England). 2021;53(10):737\u201354.","journal-title":"(London England)"},{"issue":"7","key":"8898_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699\u2013702.","journal-title":"J Med Virol"},{"issue":"1","key":"8898_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00221-021-06244-z","volume":"240","author":"S Veleri","year":"2022","unstructured":"Veleri S. Neurotropism of SARS-CoV-2 and neurological Diseases of the central nervous system in COVID-19 patients. Exp Brain Res. 2022;240(1):9\u201325.","journal-title":"Exp Brain Res"},{"key":"8898_CR51","doi-asserted-by":"crossref","unstructured":"Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021, 218(3).","DOI":"10.1084\/jem.20202135"},{"issue":"4","key":"8898_CR52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/acschemneuro.0c00793","volume":"12","author":"SJ Yong","year":"2021","unstructured":"Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573\u201380.","journal-title":"ACS Chem Neurosci"},{"key":"8898_CR53","doi-asserted-by":"publisher","first-page":"101874","DOI":"10.1016\/j.eclinm.2023.101874","volume":"58","author":"J Heine","year":"2023","unstructured":"Heine J, Schwichtenberg K, Hartung TJ, Rekers S, Chien C, Boesl F, Rust R, Hohenfeld C, Bungenberg J, Costa AS, et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. EClinicalMedicine. 2023;58:101874.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"8898_CR54","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/head.12620","volume":"55","author":"FR Taylor","year":"2015","unstructured":"Taylor FR. Tobacco, Nicotine, and Headache. Headache. 2015;55(7):1028\u201344.","journal-title":"Headache"},{"issue":"2","key":"8898_CR55","doi-asserted-by":"publisher","first-page":"333102422114631","DOI":"10.1177\/03331024221146314","volume":"43","author":"KP Peng","year":"2023","unstructured":"Peng KP, Rozen TD. Update in the understanding of new daily persistent headache. Cephalalgia. 2023;43(2):3331024221146314.","journal-title":"Cephalalgia"},{"issue":"6","key":"8898_CR56","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1468-2982.2008.01565.x","volume":"28","author":"P Irimia","year":"2008","unstructured":"Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia. 2008;28(6):626\u201330.","journal-title":"Cephalalgia"},{"issue":"8","key":"8898_CR57","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/head.13927","volume":"60","author":"D Garc\u00eda-Azor\u00edn","year":"2020","unstructured":"Garc\u00eda-Azor\u00edn D, Trigo J, Talavera B, Mart\u00ednez-P\u00edas E, Sierra \u00c1, Porta-Etessam J, Arenillas JF, Guerrero \u00c1L. Frequency and type of red flags in patients with Covid-19 and headache: a Series of 104 hospitalized patients. Headache. 2020;60(8):1664\u201372.","journal-title":"Headache"},{"issue":"1","key":"8898_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s10194-023-01639-5","volume":"24","author":"S Cheema","year":"2023","unstructured":"Cheema S, Stubberud A, Rantell K, Nachev P, Tronvik E, Matharu M. Phenotype of new daily persistent headache: subtypes and comparison to transformed chronic daily headache. J Headache Pain. 2023;24(1):109.","journal-title":"J Headache Pain"},{"issue":"8","key":"8898_CR59","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/03331024211068074","volume":"42","author":"D Garcia-Azorin","year":"2022","unstructured":"Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, Mencia \u00c1S, Segura T, Gonzalez-Garc\u00eda N, D\u00edaz-de-Ter\u00e1n J, et al. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022;42(8):804\u20139.","journal-title":"Cephalalgia"},{"issue":"6","key":"8898_CR60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/ejp.1000","volume":"21","author":"R Uniyal","year":"2017","unstructured":"Uniyal R, Paliwal VK, Tripathi A. Psychiatric comorbidity in new daily persistent headache: a cross-sectional study. Eur J Pain. 2017;21(6):1031\u20138.","journal-title":"Eur J Pain"},{"issue":"10","key":"8898_CR61","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/0333102420920644","volume":"40","author":"BL Reidy","year":"2020","unstructured":"Reidy BL, Riddle EJ, Powers SW, Slater SK, Kacperski J, Kabbouche MA, Hershey AD. Clinic-based characterization of continuous headache in children and adolescents: comparing youth with chronic migraine to those with new daily persistent headache. Cephalalgia. 2020;40(10):1063\u20139.","journal-title":"Cephalalgia"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08898-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08898-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08898-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:39:16Z","timestamp":1730839156000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08898-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8898"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08898-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3360248\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"16 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in this study involving human participants complied with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The study protocol was reviewed and approved by the Independent Bioethics Committee for Research of the National Center for Bioethics (CIBI-CENABI, in Spanish) of Venezuela (CIBI-CENABI-02\/2022). After explaining the nature of the study and the characteristics of the survey, only people who voluntarily agreed to participate and gave their informed consent online were included.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"877"}}